BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19262018)

  • 1. A case of von Recklinghausen's disease with coincident malignant peripheral nerve sheath tumor and gastrointestinal stromal tumor.
    Otomi Y; Otsuka H; Morita N; Terazawa K; Harada M; Nishitani H
    J Med Invest; 2009 Feb; 56(1-2):76-9. PubMed ID: 19262018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of (18)F-FDG PET-CT imaging in predicting the malignant potential of GIST].
    Li SX; Tang MD; Lin DY; Liu DJ; Lyu QH; Zhang JP; Cai ZH
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):821-827. PubMed ID: 29151288
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours.
    Cardona S; Schwarzbach M; Hinz U; Dimitrakopoulou-Strauss A; Attigah N; Mechtersheimer section sign G; Lehnert T
    Eur J Surg Oncol; 2003 Aug; 29(6):536-41. PubMed ID: 12875862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
    Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plurifocal malignant peripheral nerve sheath tumor demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Bertagna F; Bosio G; Biasiotto G; Savelli G; Rodella C; Giubbini R; Rosenbaum J; Alavi A
    Jpn J Radiol; 2009 Oct; 27(8):320-3. PubMed ID: 19856228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
    Chirindel A; Chaudhry M; Blakeley JO; Wahl R
    J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
    Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.
    Chander S; Westphal SM; Zak IT; Bloom DA; Zingas AP; Joyrich RN; Littrup PJ; Taub JW; Getzen TM
    Clin Nucl Med; 2004 Jul; 29(7):415-8. PubMed ID: 15192465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors.
    Otomi Y; Otsuka H; Morita N; Terazawa K; Furutani K; Harada M; Nishitani H
    J Med Invest; 2010 Aug; 57(3-4):270-4. PubMed ID: 20847527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors.
    Kamiyama Y; Aihara R; Nakabayashi T; Mochiki E; Asao T; Kuwano H; Oriuchi N; Endo K
    World J Surg; 2005 Nov; 29(11):1429-35. PubMed ID: 16222452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
    Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
    Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
    Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
    Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of non-neurogenic peripheral nerve malignancy-a case series and systematic review.
    Luna R; Fayad LM; Rodriguez FJ; Ahlawat S
    Skeletal Radiol; 2021 Jan; 50(1):201-215. PubMed ID: 32699955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CT.
    Watabe T; Tatsumi M; Watabe H; Isohashi K; Kato H; Yanagawa M; Shimosegawa E; Hatazawa J
    Ann Nucl Med; 2012 Apr; 26(3):222-7. PubMed ID: 22187313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthogranulomatous gastritis mimicking malignant GIST on F-18 FDG PET.
    Tsukada T; Nakano T; Miyata T; Sasaki S; Higashi K
    Ann Nucl Med; 2012 Nov; 26(9):752-6. PubMed ID: 22744808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET/CT findings of sarcomatous transformation in neurofibromatosis: a case report.
    Otsuka H; Graham MM; Kubo A; Nishitani H
    Ann Nucl Med; 2005 Feb; 19(1):55-8. PubMed ID: 15770975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.